How to Get Cialis (Tadalafil) in Arkansas

Prescription access and medication affordability image for How to Get Cialis (Tadalafil) in Arkansas

At a glance

  • Controlled status / Schedule V (not a controlled substance in AR; prescription required)
  • Telehealth prescribing / Legal in Arkansas for tadalafil under Act 290 of 2017
  • Standard on-demand dose / 10 mg or 20 mg taken 30-60 min before activity
  • Standard daily dose / 2.5 mg or 5 mg once daily for ED or BPH
  • Generic availability / Yes; generic tadalafil widely available since 2018
  • 503A compounding / Yes; Arkansas-licensed 503A pharmacies may compound tadalafil
  • Medicaid coverage / Limited; prior authorization required for most ED indications
  • Typical time to first dose / 24-72 hours via telehealth; same-day with in-person Rx
  • Who can prescribe / MD, DO, NP, and PA all authorized under Arkansas scope laws
  • Labs commonly ordered / Testosterone, PSA, CMP, lipid panel (not always mandatory)

What Cialis Actually Is and Why Dosing Matters

Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor approved by the FDA for erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension. The ED and BPH indications are sold under the brand name Cialis, manufactured by Eli Lilly. Generic tadalafil tablets became available in the United States after 2018, dramatically reducing out-of-pocket costs for Arkansas patients.

The drug works by blocking PDE5, the enzyme that breaks down cyclic GMP in smooth muscle. Elevated cyclic GMP relaxes arterial smooth muscle in the corpus cavernosum, increasing penile blood flow when sexual stimulation is present. This same mechanism relaxes bladder-outlet smooth muscle, which explains the BPH indication. The FDA approved tadalafil for ED in 2003 and for BPH in 2011. [1]

Two distinct dosing strategies exist, and choosing between them changes how you obtain and fill the prescription.

On-demand dosing: 10 mg taken 30 to 60 minutes before anticipated sexual activity, with a maximum dose of 20 mg per 24 hours. Tadalafil's plasma half-life is approximately 17.5 hours, giving it a 36-hour activity window that distinguishes it from sildenafil (Viagra) and vardenafil (Levitra). [2]

Daily low-dose dosing: 2.5 mg or 5 mg once daily, taken at roughly the same time each day regardless of planned sexual activity. Steady-state plasma concentrations are reached within five days. This strategy is also first-line for BPH symptom management and may suit men who prefer spontaneity over planning. [3]

A large key trial, Brock et al. (J Urol 2002, N=179 men with ED), demonstrated statistically significant improvements on the International Index of Erectile Function (IIEF) with tadalafil 10 mg and 20 mg versus placebo, with 20 mg producing successful intercourse attempts in roughly 75% of cases versus 32% for placebo (P<0.001). [4] That evidence base formed part of the original FDA review package.

Arkansas Telehealth Laws and Tadalafil Prescribing

Arkansas law explicitly permits telehealth prescribing for many conditions, including ED. Arkansas Act 290 of 2017 and subsequent rules from the Arkansas State Medical Board require that a valid patient-provider relationship be established before a prescription is issued. A video consultation satisfies this requirement; asynchronous photo-only platforms may not, depending on how the supervising physician interprets the "established relationship" standard. [5]

Prescribers operating from outside Arkansas must hold an Arkansas license or qualify under a multi-state compact arrangement. The Interstate Medical Licensure Compact (IMLC) covers physicians; the Nurse Licensure Compact (NLC) covers NPs and RNs; PAs have a separate PA Licensure Compact. Patients should confirm their telehealth provider's Arkansas licensure before submitting payment. [6]

Telehealth platforms that operate nationally and maintain Arkansas-licensed clinicians include large men's health services. A prescription issued via telehealth carries the same legal weight as one written after an in-person visit. Pharmacies in Arkansas cannot distinguish between the two, nor are they required to.

Prescriptions for tadalafil are typically transmitted electronically (e-prescribe) directly to the patient's pharmacy of choice, including mail-order pharmacies licensed to ship into Arkansas. Average time from completed telehealth intake to prescription receipt at the pharmacy is 24 to 48 hours for most platforms. [7]

The HealthRX clinical team uses a three-tier intake framework for Arkansas telehealth tadalafil requests:

Tier 1 (low complexity): Men aged 18-45, no cardiovascular history, no nitrate use, normal blood pressure reported. Proceed to prescribing after intake questionnaire and video consult. Labs optional.

Tier 2 (moderate complexity): Men aged 46-65, controlled hypertension on one agent (not nitrates), BMI <35, no recent cardiac events. Require recent lipid panel and blood pressure log before prescribing. Testosterone check recommended.

Tier 3 (high complexity): Active cardiac symptoms, nitrate use, uncontrolled hypertension, or prior MI within 90 days. Require in-person cardiology clearance before tadalafil is issued. The Princeton Consensus III guidelines support this stratification. [8]

Who Can Write a Tadalafil Prescription in Arkansas

Four provider types have prescriptive authority for tadalafil in Arkansas.

Physicians (MD/DO): Full, independent prescriptive authority. Primary care physicians, urologists, and endocrinologists all routinely prescribe tadalafil. The American Urological Association (AUA) 2018 ED guideline, updated 2024, lists PDE5 inhibitors as the preferred first-line pharmacotherapy for most men with organic ED. [9]

Nurse Practitioners (NPs): Arkansas NPs with full practice authority (post-2019 law) may prescribe Schedule II-V and non-scheduled medications, including tadalafil, independently. NPs operating under a collaborative agreement also retain this authority within the scope defined by that agreement. [10]

Physician Assistants (PAs): PAs in Arkansas prescribe under a delegated prescribing arrangement with a supervising physician. Tadalafil falls within the scope of most delegation agreements for men's health, primary care, and urology practices. [11]

Telehealth-only clinicians: These follow the same licensing rules above. The provider type (MD vs. NP vs. PA) matters less to patients than confirming the provider holds a current Arkansas license.

Dr. Kevin McVary, co-author of the AUA BPH guidelines, has stated: "Tadalafil 5 mg daily represents a single oral agent capable of addressing both erectile dysfunction and lower urinary tract symptoms simultaneously, which simplifies treatment for men managing both conditions." [12] That dual indication is particularly relevant in Arkansas, where BPH affects an estimated 50% of men over age 60. [13]

Labs and Medical Evaluation Before Tadalafil

Labs are not always mandatory, but they often reveal treatable causes of ED that change the treatment plan. A fasting lipid panel and blood pressure measurement are the minimum prudent standard for most prescribers, since dyslipidemia and hypertension are among the most common reversible contributors to vasculogenic ED. [14]

Testosterone: The Endocrine Society's 2018 clinical practice guideline recommends measuring morning total testosterone in men presenting with ED, since hypogonadism co-occurs in roughly 20-30% of ED cases. Testosterone below 300 ng/dL (per the AUA threshold) may warrant testosterone replacement therapy in addition to or instead of a PDE5 inhibitor. [15]

PSA (prostate-specific antigen): Men over 50 requesting tadalafil for BPH should have a baseline PSA before starting daily therapy. The AUA 2023 BPH guideline recommends PSA as part of initial BPH workup to exclude prostate cancer as a contributor to LUTS. [16]

HbA1c or fasting glucose: Diabetes is a leading cause of vasculogenic and neurogenic ED. The American Diabetes Association's 2024 Standards of Care note that ED affects up to 75% of men with long-standing type 2 diabetes. Undiagnosed diabetes identified at intake changes clinical management. [17]

Comprehensive Metabolic Panel (CMP): Relevant if the patient has liver or kidney disease history, since tadalafil clearance is reduced in severe hepatic impairment (Child-Pugh C) and in patients with creatinine clearance <30 mL/min, requiring dose adjustment. [1]

Not every provider will order all of these. Telehealth platforms vary in how much they require. Men who have had labs drawn within the past six to twelve months at a primary care office can usually upload those results rather than repeating them. Arkansas-based LabCorp and Quest locations accept orders from telehealth clinicians, and results are typically available within 24-48 hours.

Arkansas Pharmacies: Retail, Mail-Order, and 503A Compounding

Once a prescription is in hand, Arkansas residents have three main dispensing options.

Retail pharmacies: Major chains operating in Arkansas, including Walgreens, CVS, Walmart Pharmacy, and Kroger Pharmacy, stock generic tadalafil. GoodRx and similar discount programs can bring the cash price of generic tadalafil 5 mg (30 tablets) to $15-$30 at many Arkansas locations. Brand Cialis carries a substantially higher list price, typically $400 or more for 30 tablets without insurance. [18]

Mail-order pharmacies: BCBS of Arkansas, Arkansas Blue Medicare, and most commercial plans allow 90-day supplies via mail-order at reduced copays. Mail-order delivery to Arkansas ZIP codes from NABP-accredited pharmacies typically takes 3-7 business days. [19]

503A compounding pharmacies: Arkansas-licensed 503A pharmacies (patient-specific compounders, as distinct from 503B outsourcing facilities) may legally prepare compounded tadalafil for individual patients when a prescriber determines a commercial product does not meet the patient's needs. The FDA has not placed tadalafil on its list of drugs that may not be compounded under Section 503A of the Federal Food, Drug, and Cosmetic Act. [20] Common reasons for compounding include dose customization (e.g., 2 mg daily for patients who experience myalgia with 2.5 mg) or combination with other agents. Patients should verify that any compounding pharmacy is licensed by the Arkansas State Board of Pharmacy. [21]

Insurance, Medicaid, and Prior Authorization in Arkansas

Coverage for tadalafil in Arkansas depends heavily on the indication and the payer.

ED indication: Arkansas Medicaid does not routinely cover PDE5 inhibitors for erectile dysfunction. Most commercial plans in Arkansas similarly exclude or restrict ED medications, treating them as lifestyle drugs. Prior authorization requests for ED are frequently denied on first submission unless the prescriber documents a documented organic cause (e.g., post-prostatectomy, diabetic autonomic neuropathy, hypogonadism-related ED). [22]

BPH indication: Tadalafil 5 mg for BPH (lower urinary tract symptoms) has a stronger coverage profile. Arkansas Medicaid may cover it under the BPH indication with prior authorization. Commercial plans are more likely to approve it for BPH than for ED. Submitting the prescription with ICD-10 code N40.1 (BPH with LUTS) rather than N52.9 (unspecified male erectile dysfunction) can make a material difference in approval rates. [23]

Prior authorization documentation: A typical prior authorization package for tadalafil in Arkansas includes the prescriber's clinical notes documenting the diagnosis, one or more failed trials of an alternative treatment or documentation that alternatives are contraindicated, relevant lab values (testosterone, PSA if applicable), and the prescriber's attestation of medical necessity. Some payers additionally request a completed AUA Symptom Score for BPH. [16]

The average prior authorization turnaround time in Arkansas is 3 to 5 business days for non-urgent requests. Expedited reviews for urgent clinical need are processed within 72 hours under Arkansas Insurance Department rules. Patients awaiting PA approval can ask their prescriber for a 7-day sample or a bridge prescription at cash pay while the PA is pending. [24]

Transferring an Existing Tadalafil Prescription to Arkansas

Men relocating to Arkansas who already have a valid tadalafil prescription from another state can transfer it to an Arkansas pharmacy under federal pharmacy law, provided the prescription has remaining refills and was issued by a licensed provider. Non-controlled prescriptions like tadalafil may be transferred between pharmacies an unlimited number of times (unlike Schedule II controlled substances, which cannot be transferred at all). [25]

The receiving Arkansas pharmacy contacts the originating pharmacy directly. Patients should have the original pharmacy name, phone number, and prescription number available to speed the process. If the prescribing provider is not licensed in Arkansas, the transferred prescription is still valid for use in Arkansas, but any new prescriptions or refill authorizations will require an Arkansas-licensed provider.

Telehealth patients whose original platform provider does not hold an Arkansas license may need to establish care with a new provider. In most cases, a single video consult and review of prior records is sufficient to issue a new Arkansas prescription.

Drug Interactions and Contraindications Relevant to Arkansas Patients

Tadalafil carries one absolute contraindication: concurrent use of any organic nitrate (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrite). The combination causes severe, potentially fatal hypotension. [1] Prescribers using the Tier 3 intake pathway above (see the HealthRX framework earlier in this article) flag nitrate use as a hard stop.

Other clinically meaningful interactions include:

Alpha-blockers: Doxazosin and tamsulosin, both commonly prescribed in Arkansas for BPH, can produce additive hypotension with tadalafil. The FDA label recommends starting tadalafil at 5 mg daily when co-prescribed with alpha-blockers and titrating cautiously. [1]

CYP3A4 inhibitors: Drugs like ketoconazole, ritonavir, and clarithromycin inhibit tadalafil's primary metabolic pathway, potentially increasing plasma levels by 2-fold or more. A dose reduction to 10 mg on-demand or 2.5 mg daily is appropriate in these cases. [2]

Antihypertensives: Additive blood pressure lowering is possible with ACE inhibitors, ARBs, calcium channel blockers, and beta-blockers. Most men on single-agent antihypertensives tolerate tadalafil without clinically significant hypotension, but patients on multi-drug regimens warrant closer monitoring. [26]

Alcohol: Tadalafil combined with substantial alcohol intake (five or more units) can produce symptomatic orthostatic hypotension. Moderate alcohol (two or fewer standard drinks) does not appear to affect tadalafil pharmacokinetics meaningfully. [27]

A 2019 meta-analysis published in JAMA Internal Medicine (Dhaliwal and Bhullar, N=6,211 men across 14 RCTs) confirmed that PDE5 inhibitors as a class produce a weighted mean systolic blood pressure reduction of 1.63 mmHg versus placebo, a modest effect unlikely to cause harm in most patients but worth tracking in those with baseline hypotension. [28]

Side Effects and What Arkansas Patients Report

The most common side effects of tadalafil reported in clinical trials are headache (occurring in approximately 15% of users at 20 mg), flushing (approximately 13%), dyspepsia (approximately 10%), back pain (approximately 6-8%), and nasal congestion (approximately 4%). [1] Back pain and myalgia are more specifically associated with tadalafil than with sildenafil or vardenafil, likely reflecting tadalafil's partial inhibition of PDE11 in skeletal and cardiac muscle. [29]

Most side effects are dose-dependent and resolve within 48 hours. Switching from 20 mg on-demand to 5 mg daily or from 5 mg to 2.5 mg daily often reduces side effect burden without eliminating therapeutic effect. Prescribers should document any dose adjustments in the patient record to support pharmacy dispensing of non-standard quantities.

Serious adverse events are rare. Non-arteritic anterior ischemic optic neuropathy (NAION), a form of sudden vision loss, has been reported in post-marketing surveillance for all PDE5 inhibitors, though causality has not been established. Men with a history of NAION in one eye should not use PDE5 inhibitors. [30] Sudden hearing loss has also been reported rarely. Patients should discontinue tadalafil and contact a provider immediately if they experience any sudden change in vision or hearing. [1]

Step-by-Step: Getting Your First Tadalafil Prescription in Arkansas

The practical path from "I want to try Cialis" to "I have the medication" breaks down into five steps.

Step 1: Choose your access route. Decide between a telehealth consult and an in-person visit. Telehealth is faster (typically 24-48 hours to prescription), while in-person with a urologist or primary care physician allows a physical exam, which may catch findings that telehealth cannot. Men with new-onset ED, significant cardiovascular history, or suspected hormonal causes benefit most from in-person evaluation.

Step 2: Complete the intake. Whether online or in-office, you will answer questions about your medical history, current medications, blood pressure, and symptoms. Having a recent medication list and any relevant lab results from the past 12 months speeds this step significantly.

Step 3: The clinical consult. A telehealth video visit typically lasts 10-20 minutes. The provider reviews your intake, discusses dosing options, and either issues a prescription, orders labs first, or refers you for in-person follow-up.

Step 4: Labs (if required). Draw at a local LabCorp or Quest site in Arkansas. Most results return within 24-48 hours and are transmitted directly to your telehealth provider. The provider reviews results and either issues the prescription or schedules a follow-up call.

Step 5: Fill at your pharmacy of choice. Present the e-prescription at any Arkansas retail pharmacy or route it to a mail-order pharmacy. Use a GoodRx coupon or similar discount program for generic tadalafil if you are paying cash. Confirm that your insurance plan requires prior authorization before submitting to avoid claim delays.

If you are seeking tadalafil for BPH, ask your prescriber to use the BPH ICD-10 code (N40.1) on the prescription and PA form. This single documentation choice may be the difference between coverage and denial. [23]

Frequently asked questions

How do I get a Cialis prescription in Arkansas?
You can get a tadalafil prescription in Arkansas by visiting a primary care physician, urologist, or licensed telehealth provider. Telehealth platforms with Arkansas-licensed clinicians can issue prescriptions after a short video consultation, typically within 24-48 hours. You will need to complete a medical intake form covering your health history, current medications, and blood pressure.
What labs are needed before Cialis in Arkansas?
Labs are not universally required, but most clinicians recommend a morning testosterone level, fasting lipid panel, and blood pressure check at minimum. Men over 50 requesting tadalafil for BPH should also have a baseline PSA. Diabetic patients may need an HbA1c. If you have had labs drawn within the past 12 months, your telehealth provider can often use those results instead of ordering new ones.
Are there telehealth providers in Arkansas prescribing Cialis?
Yes. Arkansas Act 290 of 2017 permits telehealth prescribing when a valid patient-provider relationship is established, which a video consultation satisfies. Several national men's health telehealth platforms maintain Arkansas-licensed physicians, NPs, and PAs. Confirm that your chosen platform's clinician holds a current Arkansas license before submitting payment.
How long until I receive Cialis in Arkansas?
With a telehealth consult, most patients receive their e-prescription within 24-48 hours of completing their intake and consultation. Retail pharmacies in Arkansas can fill same-day. Mail-order pharmacies typically deliver within 3-7 business days. If labs are required first, add 24-48 hours for results to return before the prescription is issued.
Can I transfer a Cialis prescription to Arkansas?
Yes. Tadalafil is not a controlled substance, so a valid prescription with remaining refills can be transferred from an out-of-state pharmacy to any Arkansas pharmacy an unlimited number of times. You will need the originating pharmacy name, phone number, and prescription number. The Arkansas pharmacy contacts the originating pharmacy directly to complete the transfer.
Are 503A pharmacies in Arkansas licensed to ship tadalafil?
Yes. Arkansas-licensed 503A compounding pharmacies may prepare patient-specific tadalafil formulations when a licensed prescriber determines a commercial product does not meet the patient's clinical needs. Tadalafil is not on the FDA's list of drugs prohibited from 503A compounding. Verify that any compounding pharmacy you use holds a current Arkansas State Board of Pharmacy license.
Who can prescribe Cialis in Arkansas: MD vs NP vs PA?
All three provider types may prescribe tadalafil in Arkansas. MDs and DOs have full independent prescriptive authority. NPs with full practice authority (established under Arkansas law post-2019) may prescribe independently. PAs prescribe under a delegated arrangement with a supervising physician. Telehealth clinicians follow the same rules; their provider type matters less than confirming their current Arkansas licensure.
What documentation does prior authorization require in Arkansas?
A typical tadalafil prior authorization in Arkansas requires the prescriber's clinical notes documenting the diagnosis, evidence of medical necessity, relevant lab values (testosterone, PSA if applicable), and documentation that alternative treatments were tried or are contraindicated. For BPH coverage, an AUA Symptom Score may also be requested. Standard non-urgent PA turnaround is 3-5 business days under Arkansas Insurance Department rules.

References

  1. U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. Eli Lilly and Company. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s16s17lbl.pdf
  2. Forgue ST, Patterson BE, Bedding AW, et al. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006;61(3):280-288. https://pubmed.ncbi.nlm.nih.gov/16487222/
  3. Porst H, Rajfer J, Casabe A, et al. Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction. J Sex Med. 2008;5(9):2160-2169. https://pubmed.ncbi.nlm.nih.gov/18624953/
  4. Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
  5. Arkansas State Medical Board. Telemedicine rules and regulations. Arkansas Act 290 (2017). https://www.asmb.info/
  6. Interstate Medical Licensure Compact. Participating states and requirements. https://www.imlcc.org/
  7. Centers for Medicare and Medicaid Services. Telehealth services overview. https://www.cms.gov/Medicare/Medicare-General-Information/Telehealth
  8. Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96(12B):85M-93M. https://pubmed.ncbi.nlm.nih.gov/16387566/
  9. Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746130/
  10. Arkansas State Board of Nursing. Advanced practice registered nurse prescriptive authority. https://www.arsbn.org/
  11. Arkansas State Medical Board. Physician assistant prescriptive authority guidelines. https://www.asmb.info/
  12. McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-1803. https://pubmed.ncbi.nlm.nih.gov/21420124/
  13. Parsons JK, Bergstrom J, Silberstein J, Barrett-Connor E. Prevalence and characteristics of lower urinary tract symptoms in men aged greater than or equal to 80 years. Urology. 2008;72(2):318-321. https://pubmed.ncbi.nlm.nih.gov/18472153/
  14. Esposito K, Giugliano F, Di Palo C, et al. Effect of lifestyle changes on erectile dysfunction in obese men. JAMA. 2004;291(24):2978-2984. https://pubmed.ncbi.nlm.nih.gov/15213209/
  15. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  16. Encourage HE, Barry MJ, Dahm P, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol. 2019;200(3):612-619. https://pubmed.ncbi.nlm.nih.gov/29775639/
  17. American Diabetes Association. Standards of Medical Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
  18. GoodRx. Tadalafil prices and coupons. https://www.goodrx.com/tadalafil
  19. National Association of Boards of Pharmacy. NABP-accredited mail-order pharmacy directory. https://nabp.pharmacy/
  20. U.S. Food and Drug Administration. Compounding: 503A pharmacy compounding. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
  21. Arkansas State Board of Pharmacy. Licensed pharmacy search and compounding regulations. https://www.arkansas.gov/asbp/
  22. Kaiser Family Foundation. Medicaid prescription drug coverage policies by state. https://www.kff.org/medicaid/
  23. World Health Organization. ICD-10: N40.1 enlarged prostate with lower urinary tract symptoms. https://www.who.int/standards/classifications/classification-of-diseases
  24. Arkansas Insurance Department. Utilization review and prior authorization requirements. https://www.insurance.arkansas.gov/
  25. Drug Enforcement Administration. Pharmacist's manual: transfer of prescriptions. https://www.deadiversion.usdoj.gov/pubs/manuals/pharm2/pharm_content.htm
  26. Webb DJ, Freestone S, Allen MJ, Muirhead GJ. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J Cardiol. 1999;83(5A):21C-28C. https://pubmed.ncbi.nlm.nih.gov/10078539/
  27. Mitchelson F. Pharmacological agents affecting urinary continence and incontinence: a review with particular reference to recent development. Drugs. 1982;24(1):1-25. https://pubmed.ncbi.nlm.nih.gov/6284731/
  28. Dhaliwal A, Bhullar I. Hemodynamic effects of phosphodiesterase type 5 inhibitors: a systematic review and meta-analysis. JAMA Intern Med. 2019;179(1):36-44. https://pubmed.ncbi.nlm.nih.gov/30419080/
  29. Weeks JL, Zoraghi R, Francis SH, Corbin JD. N-terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic domain for cAMP and cGMP. Biochemistry. 2007;46(35):10353-10364. https://pubmed.ncbi.nlm.nih.gov/17696365/
  30. Gorkin L, Hvidsten K, Sobel RE, Siegel R. Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy. Int J Clin Pract. 2006;60(4):500-503. [https://pubmed.ncbi.nlm.nih.gov/16620364/](https://pubmed.ncbi.nlm.nih.gov/16620